Idorsia Ltd is reaching out for more - We have more ideas, we see more opportunities and we want to help more patients.
In order to achieve this, we will develop Idorsia into one of Europes leading biopharmaceutical company, with a strong scientific core.
Headquartered in Switzerland - a European biotech hub - Idorsia is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia has a broad portfolio of innovative drugs in the pipeline, an experienced team, a fully-functional research center, and a strong balance sheet the ideal constellation to bringing R&D efforts to business success.
Idorsia was listed on the SIX Swiss Exchange (ticker symbol: IDIA) in June 2017 and has over 600 highly qualified specialists dedicated to realizing our ambitious targets.
The Life Cycle Leader is accountable for the timely development of one or several Idorsia products to the market and an optimal lifecycle management of his/her asset(s) from entry-into-man through to patent expiration in accordance with the company strategy.
Under the leadership of the Life Cycle Leader, the life cycle teams bring global expertise from preclinical development, clinical development, chemistry, manufacturing & controls and marketing to the efficient development of new medicines.Main responsibilities and tasks:
Leads the cross-functional LCT(s) and cross functional sub-teams
Ensures efficient teamwork and cross-functional integration
Facilitates decision-making within the LCT(s) and sub-teams
Challenges and motivates team members and identifies/resolves issues and conflicts
Identifies optimal processes and tools enabling cross-functional and cross-project integration
Drives the development and implementation of the compound strategy together with the functional areas (e.g. preclinical, clinical, regulatory, CMC, marketing)
Identifies resource needs and proposes solutions
Manages the Global Development Budget (internal & external) and Forecasts for his/her compound(s):
Monitors and controls the global development budget on an ongoing basis and provides latest estimates to Finance
Identifies deviations from the budget and proposes solutions
Presents the compound strategy and recommendations to the Idorsia Management Boards
Represents the Life Cycle Team in due diligence activities supporting the Company's Business
Coordinate and overseeAlliance/Partnershipmanagement activities of his/her asset(s) under co-developments
University degree (preferable MSc, PhD or MD) or equivalent
At least 10 years experience within the pharmaceutical industry (understanding of the scientific and business aspects); thereof at least 5 years in Global Development
Strong knowledge of R&D process and regulatory environment
Demonstrated experience in working in an international, multidisciplinary environment
Min.2 years experience inleading a cross-functional project team in Life Cycle Management
Well-developed project management, communication, problem solving, and presentation skills
Strong people management and leadership skills, demonstrated success in fostering collaborative solutions
Strong strategic planning and priority setting capabilities,ability to initiate, develop, and implement changes
Demonstrated ability to understand, influence and work independently and effectively in cross-functional teams and matrix organizations
Fluent in English (German and French an advantage)
Business Area:Global Clinical Development
Job ID: 1672
If you are interested, please click on apply now.
Please be informed that if you are selected for this position, your employment will be subject to a pre-employment background screening process, of which you would be informed in greater detail in due course.
Please note Idorsia operates a strictly-controlled list of preferred recruitment partners. For those partners who have no valid, signed Master Service Agreement in place with Idorsia all unsolicited resumes, CVs, anonymous profiles, or any other candidate details submitted through our website or to personal e-mail accounts of employees of Idorsia Pharmaceuticals (including any of its subsidiaries, affiliates or related companies) are considered the property of Idorsia Pharmaceuticals and are not subject to payment of any form of introduction, placement or referral fees.